Moreover, in sepsis-induced cardiac injury, delivery of basic-FGF via nanoparticles as a carrier has been shown to treat sepsis-induced cardiac injury and protect cardiomyocytes from oxidative and inflammatory damage (48). This evidence concerns the gene ASIC5 and Sepsis.